Explore
Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond
0 Ungluers have
Faved this Work
Login to Fave
Current regulatory guidelines for cardiac safety utilize hERG block and QT interval prolongation as risk markers. This strategy has been successful at preventing harmful drugs from being marketed, but criticized for leading to early withdrawal of potentially safe drugs. Here we collected a series of articles presenting new technological and conceptual advances, including refinement of ex vivo and in vitro assays, screens and models, and in silico approaches reflecting the increasing effort that has been put forward by regulatory agencies, industry, and academia to try and address the need of a more accurate, mechanistically-based paradigm of proarrhythmic potential of drugs.This Research Topic is dedicated to the memory of Dr. J. Jeremy Rice, our wonderful friend and colleague.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 115 times via unglue.it ebook links.
- 50 - mobi (CC BY) at Unglue.it.
- 34 - epub (CC BY) at Unglue.it.
- 31 - pdf (CC BY) at Unglue.it.
Keywords
- cardiac electrophysiology.
- cardiotoxicity
- drug-induced arrhythmia
- Multi-scale modeling
- QT interval prolongation
- thema EDItEUR::M Medicine and Nursing::MF Pre-clinical medicine: basic sciences::MFG Physiology
Links
DOI: 10.3389/978-2-88945-539-3Editions